18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
| Autor: | Huddart RA, O'Doherty MJ, Padhani A, Rustin GJ, Mead GM, Joffe JK, Vasey P, Harland SJ, Logue J, Daugaard G, Hain SF, Kirk SJ, MacKewn JE, Stenning SP, NCRI Testis Tumour Clinical Study Group, Huddart, Robert A, O'Doherty, Michael J, Padhani, Anwar, Rustin, Gordon J S, Mead, Graham M |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 7/20/2007, Vol. 25 Issue 21, p3090-3095, 6p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|